Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Management of optic neuritis.

Menon V, Saxena R, Misra R, Phuljhele S.

Indian J Ophthalmol. 2011 Mar-Apr;59(2):117-22. doi: 10.4103/0301-4738.77020.

2.

Acute demyelinating optic neuritis.

Foroozan R, Buono LM, Savino PJ, Sergott RC.

Curr Opin Ophthalmol. 2002 Dec;13(6):375-80. Review.

PMID:
12441840
3.

Intravenous immunoglobulin and interferon: successful treatment of optic neuritis in pediatric multiple sclerosis.

Spalice A, Properzi E, Lo Faro V, Acampora B, Iannetti P.

J Child Neurol. 2004 Aug;19(8):623-6.

PMID:
15605474
4.

Blurred vision and pain in the eye.

Barnett MH, Chohan G, Davies L.

Med J Aust. 2011 Sep 19;195(6):329-32.

PMID:
21929496
5.

Optic neuritis and risk of MS: differential diagnosis and management.

Osborne BJ, Volpe NJ.

Cleve Clin J Med. 2009 Mar;76(3):181-90. doi: 10.3949/ccjm.76a.07268. Review.

PMID:
19258465
6.

Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses.

Beck RW, Chandler DL, Cole SR, Simon JH, Jacobs LD, Kinkel RP, Selhorst JB, Rose JW, Cooper JA, Rice G, Murray TJ, Sandrock AW.

Ann Neurol. 2002 Apr;51(4):481-90.

PMID:
11921054
7.

Interferon beta-1a for optic neuritis patients at high risk for multiple sclerosis.

CHAMPS Study Group.

Am J Ophthalmol. 2001 Oct;132(4):463-71.

PMID:
11589865
8.

Optic neuritis.

Vaphiades MS, Kline LB.

Compr Ophthalmol Update. 2007 Mar-Apr;8(2):67-75; discussion 77-8. Review.

PMID:
17540123
9.

[Treatment of optic neuritis].

van der Worp HB, van Gijn J, Plant GT.

Ned Tijdschr Geneeskd. 2004 Jan 10;148(2):61-5. Review. Dutch.

PMID:
14753126
10.

Comparing the cost-effectiveness of disease-modifying drugs for the first-line treatment of relapsing-remitting multiple sclerosis.

Goldberg LD, Edwards NC, Fincher C, Doan QV, Al-Sabbagh A, Meletiche DM.

J Manag Care Pharm. 2009 Sep;15(7):543-55.

11.

Optic neuritis in adults and children.

Boomer JA, Siatkowski RM.

Semin Ophthalmol. 2003 Dec;18(4):174-80. Review.

PMID:
15513003
12.

The effect of interferon beta-1a on optic neuritis relapse in patients with multiple sclerosis.

Chen YM, Yang CC, Wang IH, Hu FR, Jou JR.

Graefes Arch Clin Exp Ophthalmol. 2010 Feb;248(2):231-5. doi: 10.1007/s00417-009-1207-2. Epub 2009 Oct 6.

PMID:
19806357
13.

Optic neuritis and multiple sclerosis.

Söderström M.

Acta Ophthalmol Scand. 2001 Jun;79(3):223-7. Review.

14.

Repeated intervals of high-dose corticosteroid: an overlooked therapy in multiple sclerosis.

Johnson LN, Morey SS.

Mo Med. 2005 Jan-Feb;102(1):47-50. Review.

PMID:
15754617
15.

Optic neuritis in multiple sclerosis.

Chan JW.

Ocul Immunol Inflamm. 2002 Sep;10(3):161-86. Review.

PMID:
12789593
16.

Management of optic neuritis and multiple sclerosis.

Van Stavern GP.

Curr Opin Ophthalmol. 2001 Dec;12(6):400-7. Review.

PMID:
11734679
17.

Clinical practice. Optic neuritis.

Balcer LJ.

N Engl J Med. 2006 Mar 23;354(12):1273-80. Review. No abstract available.

PMID:
16554529
18.

Optic neuritis, its differential diagnosis and management.

Hoorbakht H, Bagherkashi F.

Open Ophthalmol J. 2012;6:65-72. doi: 10.2174/1874364101206010065. Epub 2012 Jul 24.

19.

Early relapse in multiple sclerosis-associated optic neuritis following the use of interferon beta-1a in Chinese patients.

Wang AG, Lin YC, Wang SJ, Tsai CP, Yen MY.

Jpn J Ophthalmol. 2006 Nov-Dec;50(6):537-42. Epub 2006 Dec 18.

PMID:
17180529
20.

Fellow eye abnormalities in acute unilateral optic neuritis. Experience of the optic neuritis treatment trial.

Beck RW, Kupersmith MJ, Cleary PA, Katz B.

Ophthalmology. 1993 May;100(5):691-7; discussion 697-8.

PMID:
8493012

Supplemental Content

Support Center